2023 Q1 Form 10-K Financial Statement
#000147793223002099 Filed on March 31, 2023
Income Statement
Concept | 2023 Q1 | 2022 Q4 | 2022 |
---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Cost Of Revenue | $0.00 | $0.00 | |
YoY Change | |||
Gross Profit | $0.00 | $0.00 | |
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $3.517M | $1.377M | $3.826M |
YoY Change | 517.1% | 49.06% | |
% of Gross Profit | |||
Research & Development | $207.3K | $94.44K | $1.274M |
YoY Change | -29.25% | 2960.65% | |
% of Gross Profit | |||
Depreciation & Amortization | $0.00 | $0.00 | |
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $3.725M | $1.472M | $5.099M |
YoY Change | 334.0% | 95.51% | |
Operating Profit | -$3.725M | -$5.099M | |
YoY Change | 334.0% | ||
Interest Expense | -$540.00 | $1.480K | $3.380K |
YoY Change | 2716.67% | ||
% of Operating Profit | |||
Other Income/Expense, Net | $109.7K | $166.2K | $153.9K |
YoY Change | 16403.16% | ||
Pretax Income | -$3.615M | -$1.304M | -$4.945M |
YoY Change | 320.36% | 89.62% | |
Income Tax | $0.00 | $0.00 | |
% Of Pretax Income | |||
Net Earnings | -$3.615M | -$1.304M | -$4.945M |
YoY Change | 321.54% | 89.62% | |
Net Earnings / Revenue | |||
Basic Earnings Per Share | -$0.12 | -$0.18 | |
Diluted Earnings Per Share | -$0.12 | -$0.06 | -$0.18 |
COMMON SHARES | |||
Basic Shares Outstanding | 37.39M shares | 34.36M shares | 26.79M shares |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2023 Q1 | 2022 Q4 | 2022 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $5.082M | $2.389M | $2.389M |
YoY Change | -19.11% | ||
Cash & Equivalents | $5.082M | $2.389M | |
Short-Term Investments | |||
Other Short-Term Assets | $688.3K | $913.0K | $913.0K |
YoY Change | 241.24% | ||
Inventory | |||
Prepaid Expenses | |||
Receivables | $0.00 | ||
Other Receivables | |||
Total Short-Term Assets | $5.771M | $3.302M | $3.302M |
YoY Change | 2.51% | 2.51% | |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $8.006M | $8.201M | $9.054M |
YoY Change | 174.43% | 130.9% | |
Goodwill | $0.00 | ||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $133.6K | $139.6K | $139.6K |
YoY Change | |||
Total Long-Term Assets | $8.836M | $9.194M | $9.194M |
YoY Change | 134.46% | 134.46% | |
TOTAL ASSETS | |||
Total Short-Term Assets | $5.771M | $3.302M | $3.302M |
Total Long-Term Assets | $8.836M | $9.194M | $9.194M |
Total Assets | $14.61M | $12.50M | $12.50M |
YoY Change | 74.95% | 74.95% | |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $1.287M | $1.355M | $1.355M |
YoY Change | 2170.32% | 2170.27% | |
Accrued Expenses | $408.6K | $361.2K | $407.2K |
YoY Change | 749.99% | 405.34% | |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $33.85K | $33.85K | $33.85K |
YoY Change | -27.83% | ||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $1.996M | $1.936M | $1.936M |
YoY Change | 538.32% | 538.33% | |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $698.0K | $742.4K | $742.4K |
YoY Change | -11.78% | ||
Total Long-Term Liabilities | $698.0K | $742.4K | $742.4K |
YoY Change | -11.78% | ||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $1.996M | $1.936M | $1.936M |
Total Long-Term Liabilities | $698.0K | $742.4K | $742.4K |
Total Liabilities | $2.694M | $2.679M | $2.679M |
YoY Change | 133.96% | 133.96% | |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$11.17M | -$7.553M | |
YoY Change | 189.62% | ||
Common Stock | $373.9K | $359.1K | |
YoY Change | 73.86% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $11.91M | $9.817M | $9.817M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $14.61M | $12.50M | $12.50M |
YoY Change | 74.95% | 74.95% |
Cashflow Statement
Concept | 2023 Q1 | 2022 Q4 | 2022 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$3.615M | -$1.304M | -$4.945M |
YoY Change | 321.54% | 89.62% | |
Depreciation, Depletion And Amortization | $0.00 | $0.00 | |
YoY Change | |||
Cash From Operating Activities | -$1.445M | -$862.0K | -$2.940M |
YoY Change | 401.82% | 408.9% | |
INVESTING ACTIVITIES | |||
Capital Expenditures | $362.1K | $902.5K | $4.473M |
YoY Change | -59.72% | 49.69% | |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | -$362.1K | -$902.5K | -$4.473M |
YoY Change | -59.72% | 49.69% | |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $8.120M | ||
YoY Change | 21.56% | ||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | $4.494M | 3.790M | $6.641M |
YoY Change | 101.24% | 2.16% | |
NET CHANGE | |||
Cash From Operating Activities | -$1.445M | -862.0K | -$2.940M |
Cash From Investing Activities | -$362.1K | -902.5K | -$4.473M |
Cash From Financing Activities | $4.494M | 3.790M | $6.641M |
Net Change In Cash | $2.687M | 2.026M | -$772.0K |
YoY Change | 156.82% | -126.3% | |
FREE CASH FLOW | |||
Cash From Operating Activities | -$1.445M | -$862.0K | -$2.940M |
Capital Expenditures | $362.1K | $902.5K | $4.473M |
Free Cash Flow | -$1.807M | -$1.765M | -$7.413M |
YoY Change | 52.25% | 107.89% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001921865 | |
CY2022 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2022 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2022 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2022 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
20652500 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
35907127 | shares |
CY2021Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2021Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2021Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2021Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
342200 | usd | |
CY2022 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
380747 | usd |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
|
700000 | usd |
CY2022 | dei |
Document Type
DocumentType
|
10-K | |
CY2022 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2022 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2022-12-31 | |
CY2022 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2022 | dei |
Entity File Number
EntityFileNumber
|
001-39069 | |
CY2022 | dei |
Entity Registrant Name
EntityRegistrantName
|
ASP Isotopes Inc. | |
CY2022 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | |
CY2022 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
87-2618235 | |
CY2022 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
433 Plaza Real | |
CY2022 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 275 | |
CY2022 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Boca Raton | |
CY2022 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
FL | |
CY2022 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
33432 | |
CY2022 | dei |
City Area Code
CityAreaCode
|
561 | |
CY2022 | dei |
Local Phone Number
LocalPhoneNumber
|
709-3034 | |
CY2022 | dei |
Security12b Title
Security12bTitle
|
Common stock, par value $0.01 per share | |
CY2022 | dei |
Trading Symbol
TradingSymbol
|
ASPI | |
CY2022 | dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | |
CY2022 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2022 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2022 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
No | |
CY2022 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2022 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2022 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2022 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
CY2022 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | |
CY2022 | dei |
Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
|
false | |
CY2022 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2022Q2 | dei |
Entity Public Float
EntityPublicFloat
|
8100000 | usd |
CY2023Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
37385684 | shares |
CY2022 | dei |
Auditor Firm
AuditorFirmId
|
274 | |
CY2022 | dei |
Auditor Name
AuditorName
|
EisnerAmper LLP | |
CY2022 | dei |
Auditor Location
AuditorLocation
|
Iselin, New Jersey | |
CY2022Q4 | us-gaap |
Cash
Cash
|
2389140 | usd |
CY2021Q4 | us-gaap |
Cash
Cash
|
2953721 | usd |
CY2022Q4 | f10q0922 |
Fair Value Of Shares Issuable
FairValueOfSharesIssuable
|
140455 | usd |
CY2021Q4 | f10q0922 |
Fair Value Of Shares Issuable
FairValueOfSharesIssuable
|
116200 | usd |
us-gaap |
Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
|
18723 | usd | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
20652500 | shares |
CY2022 | f10q0922 |
Change In Fair Value Of Share Liability
ChangeInFairValueOfShareLiability
|
150527 | usd |
f10q0922 |
Change In Fair Value Of Share Liability
ChangeInFairValueOfShareLiability
|
0 | usd | |
CY2022 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
3382 | usd |
us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
115 | usd | |
CY2022 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
153909 | usd |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
115 | usd | |
CY2022 | us-gaap |
Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
|
-4945139 | usd |
us-gaap |
Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
|
-2607927 | usd | |
CY2022 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.18 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.16 | ||
CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
26793748 | shares |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
16246432 | shares | |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4945139 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-2607927 | usd | |
CY2022 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
236307 | usd |
us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
18723 | usd | |
CY2022 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-4708832 | usd |
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-2589204 | usd | |
CY2021Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
0 | usd |
us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
500000 | usd | |
us-gaap |
Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
0 | usd | |
us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
6337800 | usd | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
1735841 | usd | |
us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
13227 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-2607927 | usd | |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
5997664 | usd |
CY2022 | f10q0922 |
Stock Issued During Period Values
StockIssuedDuringPeriodValues
|
2738812 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
1209496 | usd |
CY2022 | f10q0922 |
Proceeds From Issuance Of Common Stock Issue
ProceedsFromIssuanceOfCommonStockIssue
|
3790504 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
0 | usd |
CY2022 | f10q0922 |
Issuance Of Restricted Shares Amount
IssuanceOfRestrictedSharesAmount
|
0 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
1999313 | usd |
CY2022 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
|
236307 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4945139 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
9817461 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4945139 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-2607927 | usd | |
CY2022 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1999313 | usd |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
13227 | usd | |
CY2022 | f10q0922 |
Issuance Of Common Stock To Founders
IssuanceOfCommonStockToFounders
|
0 | usd |
f10q0922 |
Issuance Of Common Stock To Founders
IssuanceOfCommonStockToFounders
|
500000 | usd | |
CY2022 | f10q0922 |
Issuance Of Warrant To Purchase Common Stock
IssuanceOfWarrantToPurchaseCommonStock
|
0 | usd |
f10q0922 |
Issuance Of Warrant To Purchase Common Stock
IssuanceOfWarrantToPurchaseCommonStock
|
1735841 | usd | |
CY2022 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
50000 | usd |
us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
0 | usd | |
CY2022 | us-gaap |
Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
|
-150527 | usd |
us-gaap |
Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
|
0 | usd | |
CY2022 | us-gaap |
Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
|
72570 | usd |
us-gaap |
Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
|
19376 | usd | |
CY2022 | us-gaap |
Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
|
-671924 | usd |
us-gaap |
Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
|
-267562 | usd | |
CY2022 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
-146435 | usd |
us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
0 | usd | |
CY2022 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
570600 | usd |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
59679 | usd | |
CY2022 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
319048 | usd |
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
42500 | usd | |
CY2022 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-37399 | usd |
us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-72826 | usd | |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-2939893 | usd |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-577692 | usd | |
CY2022 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
4473164 | usd |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
2988210 | usd | |
CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-4473164 | usd |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-2988210 | usd | |
CY2022 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
8119959 | usd |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
6680000 | usd | |
CY2022 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
1465461 | usd |
us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
226000 | usd | |
CY2022 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
0 | usd |
us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
46900 | usd | |
CY2022 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
13046 | usd |
us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
0 | usd | |
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
6641052 | usd |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
6500900 | usd | |
CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-772005 | usd |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
2934998 | usd | |
CY2022 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
207424 | usd |
us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
18723 | usd | |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
2953721 | usd |
CY2021Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
0 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
2389140 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
2953721 | usd |
CY2022 | us-gaap |
Stock Issued1
StockIssued1
|
124782 | usd |
CY2022 | us-gaap |
Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
|
6050000 | usd |
us-gaap |
Stock Issued1
StockIssued1
|
116200 | usd | |
CY2022 | us-gaap |
Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
|
745628 | usd |
us-gaap |
Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
|
0 | usd | |
CY2022 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
0 | usd |
us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
952521 | usd | |
CY2022Q4 | us-gaap |
Share Price
SharePrice
|
4.00 | |
CY2022Q4 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
3800000 | usd |
CY2022 | us-gaap |
Income Loss Attributable To Parent
IncomeLossAttributableToParent
|
4945139 | usd |
us-gaap |
Income Loss Attributable To Parent
IncomeLossAttributableToParent
|
2607927 | usd | |
CY2022Q4 | us-gaap |
Cash
Cash
|
2389140 | usd |
CY2022 | f10q0922 |
Amount Received
AmountReceived
|
gross proceeds of $5.0 million received in March 2023 through the issuance of 3,164,557 shares of the Company's common stock | |
CY2022 | us-gaap |
Common Stock Convertible Conversion Price Decrease
CommonStockConvertibleConversionPriceDecrease
|
1.58 | |
CY2022 | f10q0922 |
Warrants Purchase Aggregate
WarrantsPurchaseAggregate
|
3164557 | shares |
CY2022Q4 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
1.75 | |
CY2022 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The Company’s consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). The preparation of the Company’s consolidated financial statements requires management to make estimates and assumptions that impact the reported amounts of assets, liabilities and expenses and disclosure in the Company’s consolidated financial statements and accompanying notes. The most significant estimates in the Company’s consolidated financial statements relate to the valuation of equity instruments and estimating our accrued research and development expenses. Although these estimates are based on the Company’s knowledge of current events and actions it may undertake in the future, actual results may materially differ from these estimates and assumptions.</p> | |
CY2022 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:0.5in"> </p><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:0.5in">Cash balances are maintained at U.S. financial institutions and may exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limit of $250,000 per depositor, per insured bank for each account ownership category. Although the Company currently believes that the financial institutions with whom it does business, will be able to fulfill their commitments to the Company, there is no assurance that those institutions will be able to continue to do so. The Company has not experienced any credit losses associated with its balances in such accounts for the years ended December 31, 2022 and 2021.</p><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:0.5in"> </p><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:0.5in">Our foreign subsidiaries held cash of approximately $38,000 and $20,000 as of December 31, 2022 and 2021, respectively, which is included in cash on the consolidated balance sheets. Our strategic plan does not require the repatriation of foreign cash in order to fund our operations in the U.S., and it is our current intention to indefinitely reinvest our foreign cash outside of the U.S. If we were to repatriate foreign cash to the U.S., we would be required to accrue and pay U.S. taxes in accordance with applicable U.S. tax rules and regulations as a result of the repatriation.</p> | |
CY2022Q4 | f10q0922 |
Federal Deposit Insurance
FederalDepositInsurance
|
250000 | usd |
CY2022Q4 | us-gaap |
Common Stock Held By Subsidiary
CommonStockHeldBySubsidiary
|
38000 | usd |
CY2021Q4 | us-gaap |
Common Stock Held By Subsidiary
CommonStockHeldBySubsidiary
|
20000 | usd |
CY2022Q4 | us-gaap |
Fair Value Net Asset Liability
FairValueNetAssetLiability
|
140455 | usd |
CY2021Q3 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
0 | usd |
CY2021Q4 | f10q0922 |
Addition On Issuance Of Common Stock
AdditionOnIssuanceOfCommonStock
|
116200 | usd |
CY2021Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
116200 | usd |
CY2022 | f10q0922 |
Addition On Issuance Of Common Stock
AdditionOnIssuanceOfCommonStock
|
174782 | usd |
CY2022 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-150527 | usd |
CY2022Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
140455 | usd |
CY2022Q4 | us-gaap |
Construction In Progress Gross
ConstructionInProgressGross
|
8200595 | usd |
CY2021Q4 | us-gaap |
Construction In Progress Gross
ConstructionInProgressGross
|
2988210 | usd |
CY2022Q4 | us-gaap |
Notes Payable
NotesPayable
|
10000 | usd |
CY2022Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
33854 | usd |
CY2022 | us-gaap |
Loss On Contracts
LossOnContracts
|
6800000 | usd |
CY2022Q4 | us-gaap |
Other Commitment
OtherCommitment
|
7233000 | usd |
CY2021Q4 | us-gaap |
Other Commitment
OtherCommitment
|
1800000 | usd |
CY2021Q4 | us-gaap |
Subordinated Borrowing Interest Rate
SubordinatedBorrowingInterestRate
|
0.075 | pure |
CY2021Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
952521 | usd |
CY2021Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
952521 | usd |
CY2022Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
853889 | usd |
CY2022Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
45903 | usd |
CY2022Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
742443 | usd |
CY2022 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
125667 | usd |
CY2021Q4 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
19376 | usd |
CY2022 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
93211 | usd |
CY2021Q4 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
26582 | usd |
CY2022 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
0 | usd |
CY2021Q4 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
952521 | usd |
CY2022 | f10q0922 |
Remaining Lease Term Years
RemainingLeaseTermYears
|
P8Y | |
CY2021Q4 | f10q0922 |
Remaining Lease Term Years
RemainingLeaseTermYears
|
P9Y | |
CY2022 | us-gaap |
Malpractice Loss Contingency Discount Rate
MalpracticeLossContingencyDiscountRate
|
0.075 | pure |
CY2021Q4 | us-gaap |
Malpractice Loss Contingency Discount Rate
MalpracticeLossContingencyDiscountRate
|
0.075 | pure |
CY2022Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
103543 | usd |
CY2022Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
111308 | usd |
CY2022Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
119656 | usd |
CY2022Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
128631 | usd |
CY2022Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
|
138278 | usd |
CY2022Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
480229 | usd |
CY2022Q4 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
1081645 | usd |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
293299 | usd |
CY2022Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
788346 | usd |
CY2022Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
45903 | usd |
CY2022Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
742443 | usd |
CY2022Q1 | us-gaap |
Other Research And Development Expense
OtherResearchAndDevelopmentExpense
|
100000 | usd |
CY2022Q1 | f10q0922 |
Royalty Percentage On Sale Of Products
RoyaltyPercentageOnSaleOfProducts
|
0.10 | pure |
CY2022Q3 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
6000000 | zar |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
|
0.765 | pure |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.0021 | pure |
CY2022 | f10q0922 |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm
|
P2Y | |
CY2022 | f10q0922 |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumption Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionExpectedDividendRate
|
0 | pure |
CY2022Q4 | us-gaap |
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
|
6000000 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
|
5000000 | shares |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
400000 | shares | |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
400000 | shares |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.25 | |
f10q0922 |
Weighted Average Remaining Contractual Term
WeightedAverageRemainingContractualTerm
|
P9Y9M18D | ||
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
700000 | usd |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
2751000 | shares |
CY2022 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
2.00 | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
250000 | shares |
CY2022 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0.25 | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
2901000 | shares |
CY2022 | f10q0922 |
Weighted Average Remaining Contractual Term
WeightedAverageRemainingContractualTerm
|
P1Y10M28D | |
CY2022 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
|
P9Y4M24D | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
199500 | usd |
CY2022 | f10q0922 |
Number Of Options Exercisable
NumberOfOptionsExercisable
|
418749 | shares |
CY2022 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Other Share Increase Decrease In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice
|
1.76 | |
CY2022 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
|
P9Y3M18D | |
CY2022 | f10q0922 |
Aggregate Intrinsic Value Exercisable
AggregateIntrinsicValueExercisable
|
77583 | usd |
CY2022 | f10q0922 |
Number Of Options Vested Or Expected To Vests
NumberOfOptionsVestedOrExpectedToVests
|
2901000 | shares |
CY2022 | f10q0922 |
Weighted Average Exercise Price Per Share Vested Or Expected To Vest
WeightedAverageExercisePricePerShareVestedOrExpectedToVest
|
1.91 | |
CY2022 | f10q0922 |
Weighted Average Remaining Contractual Termin Years Vested Or Expected To Vest
WeightedAverageRemainingContractualTerminYearsVestedOrExpectedToVest
|
P9Y4M24D | |
CY2022 | f10q0922 |
Aggregate Intrinsic Value Vested Or Expected To Vest
AggregateIntrinsicValueVestedOrExpectedToVest
|
199500 | usd |
CY2021Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
0 | shares |
CY2021Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
0 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
2100000 | shares | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
0.25 | ||
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
2100000 | shares |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
0.25 | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
5250000 | shares |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
2.24 | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
|
350000 | shares |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
|
1.00 | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
7000000 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
1.75 | |
CY2022 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1999313 | usd |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
513227 | usd | |
CY2022 | us-gaap |
Profit Loss
ProfitLoss
|
-4945139 | usd |
us-gaap |
Profit Loss
ProfitLoss
|
-2607927 | usd | |
CY2022 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
26793745 | shares |
us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
16246432 | shares | |
CY2022 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.18 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.16 | ||
CY2022Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
496751 | usd |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
2901000 | shares |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
400000 | shares |
CY2022Q4 | f10q0922 |
Restricted Stock
RestrictedStock
|
7000000 | shares |
CY2021Q4 | f10q0922 |
Restricted Stock
RestrictedStock
|
0 | shares |
CY2022 | f10q0922 |
Warrants To Purchase Common Stock
WarrantsToPurchaseCommonStock
|
0 | shares |
f10q0922 |
Warrants To Purchase Common Stock
WarrantsToPurchaseCommonStock
|
7230822 | shares | |
CY2022 | f10q0922 |
Shares Of Common Stock Equivalents
SharesOfCommonStockEquivalents
|
9901000 | shares |
f10q0922 |
Shares Of Common Stock Equivalents
SharesOfCommonStockEquivalents
|
7630822 | shares | |
CY2022 | us-gaap |
Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
|
-4945139 | usd |
us-gaap |
Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
|
-2607927 | usd | |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.2100 | pure |
us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.2100 | pure | |
CY2022 | f10q0922 |
Earnings In Jurisdictions Taxed At Rates Different From The Statutory Us Federal Tax Rate
EarningsInJurisdictionsTaxedAtRatesDifferentFromTheStatutoryUSFederalTaxRate
|
-0.0589 | pure |
f10q0922 |
Earnings In Jurisdictions Taxed At Rates Different From The Statutory Us Federal Tax Rate
EarningsInJurisdictionsTaxedAtRatesDifferentFromTheStatutoryUSFederalTaxRate
|
0.0411 | pure | |
CY2022 | f10q0922 |
Permanent Differences Income Tax Rate
PermanentDifferencesIncomeTaxRate
|
0.0064 | pure |
f10q0922 |
Permanent Differences Income Tax Rate
PermanentDifferencesIncomeTaxRate
|
-0.2295 | pure | |
CY2022 | f10q0922 |
Other Statutory Rate
OtherStatutoryRate
|
0.0298 | pure |
f10q0922 |
Other Statutory Rate
OtherStatutoryRate
|
0 | pure | |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.1873 | pure |
us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.0216 | pure | |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd | |
CY2021Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
140241 | usd |
CY2022Q4 | f10q0922 |
Capitalized Rd Costs
CapitalizedRDCosts
|
50289 | usd |
CY2021Q4 | f10q0922 |
Capitalized Rd Costs
CapitalizedRDCosts
|
0 | usd |
CY2022Q4 | us-gaap |
Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
|
418019 | usd |
CY2021Q4 | us-gaap |
Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
|
0 | usd |
CY2022Q4 | f10q0922 |
Right Of Use Lease Liability
RightOfUseLeaseLiability
|
243113 | usd |
CY2021Q4 | f10q0922 |
Right Of Use Lease Liability
RightOfUseLeaseLiability
|
264249 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
1208172 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
404490 | usd |
CY2022Q4 | f10q0922 |
Deferred Tax Assets
DeferredTaxAssets
|
977622 | usd |
CY2021Q4 | f10q0922 |
Deferred Tax Assets
DeferredTaxAssets
|
51518 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
977622 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
51518 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | usd |
CY2022 | us-gaap |
Real Estate Owned Valuation Allowance Valuation Increase
RealEstateOwnedValuationAllowanceValuationIncrease
|
926104 | usd |
CY2022 | us-gaap |
Common Stock Convertible Conversion Price Decrease
CommonStockConvertibleConversionPriceDecrease
|
1.58 |